Finesse Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Kalol, Gujarat, India, established in 1985.
1985 Kalol, Gujarat, India Active
Last Updated:
Access Report
About Finesse Pharmaceuticals Private Limited

Finesse Pharmaceuticals Private Limited, a active private limited company, was established on 16 January 1985 in Kalol, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U85100GJ1985PTC007568. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.50 M and a paid-up capital of ₹4.09 M.

It upholds a compliant status. Employing 10 professional, Its leadership includes Rajshree Pradeep Kothari (Director), Prasann Bharatkumar Shah (Additional Director). Past directors included Harsh Pradeep Kothari, Pradeep Ravichandra Kothari, Rajshree Pradeep Kothari. It holds ₹4.87 Cr open charges and ₹2.15 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 827/6 C P Industrial Estate Santej - Rakanpur, Kalol, Gujarat, 382721.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100GJ1985PTC007568

  • Registration Number

    007568

  • Incorporation Date

    16 January 1985

  • Authorized Capital

    ₹5.50 M

  • Paid-Up Capital

    ₹4.09 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 M
  • Paid Up Capital ₹ 4.09 M
  • Company Age 41 Year, 30 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.87 Cr
  • Satisfied Charges ₹ 2.15 M
  • Revenue Growth **** 0.15%
  • Profit Growth **** 20.89%
  • Ebitda **** 2.34%
  • Net Worth 56.42%
  • Total Assets -12.08%
Company report

Finesse Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Finesse Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Finesse Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajshree Pradeep Kothari Director 03 Jan 2023 Current
Prasann Bharatkumar Shah Additional Director 08 Nov 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Director 01 Apr 2019 Past
Pramod Abcsdd Director 18 Jun 2024 Past
Pramod Abcsdd Managing Director 10 Mar 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Finesse Pharmaceuticals.

Finesse Pharmaceuticals Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.15% increase. The company also saw a substantial improvement in profitability, with a 20.89% increase in profit. The company's net worth Soared by an impressive increase of 56.42%.

Finesse Pharmaceuticals revenue growth over time
Finesse Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.15%
*******
*******
*******
*******
Revenue from Operations
*******
 0.11%
*******
*******
*******
*******
Total Assets
*******
 -12.08%
*******
*******
*******
*******
Profit or Loss
*******
 20.89%
*******
*******
*******
*******
Net Worth
*******
 56.42%
*******
*******
*******
*******
EBITDA
*******
 2.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Finesse Pharmaceuticals?

Unlock access to Finesse Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹48,657,000.00

Satisfied Charges

₹2,152,000.00

Charges Breakdown by Lending Institutions
  • Sidbi : 2.99 Cr
  • Canara Bank : 1.88 Cr
Latest Charge Details
Date Lender Amount Status
01 Jul 2025 Sidbi ₹2.99 Cr Open
21 Apr 2007 Canara Bank ₹0.41 M Open
11 Feb 2006 Canara Bank ₹1.83 Cr Open
03 Oct 2011 Canara Bank ₹1.15 M Satisfied
16 Feb 1998 Progressive Merantile Co-Op Bank Ltd ₹1.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Finesse Pharmaceuticals?

Finesse Pharmaceuticals has a workforce of 10 employees as of Mar 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Finesse Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finesse Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Finesse Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Sidbi amounted to Rs. 29.90 M with Charge ID 101116338 was registered on 01 Jul 2025. was recorded as a recent event.

  • Director Appointment

    The activity Prasann Bharatkumar Shah was appointed as a Additional Director was appointed as a Additional Director on 08 Nov 2024 & has been associated with this company since 1 year 3 months . was completed.

  • Annual General Meeting

    Finesse Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Finesse Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.

  • Charges

    A charge with Canara Bank of Rs. 18.35 M registered on 11 Feb 2006 with Charge ID 80029051 was modified on 11 Jan 2023. was recorded as a recent event.

  • Director Appointment

    Rajshree Pradeep Kothari was appointed as a Director was appointed as a Director on 03 Jan 2023 & has been associated with this company since 3 years 1 month . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Finesse Pharmaceuticals Private Limited?

The CIN of Finesse Pharmaceuticals Private Limited is U85100GJ1985PTC007568.

Where is Finesse Pharmaceuticals Private Limited headquartered?

Finesse Pharmaceuticals Private Limited is headquartered at 827/6 C P Industrial Estate Santej - Rakanpur, Kalol, Gujarat, 382721.

When was Finesse Pharmaceuticals Private Limited incorporated?

Finesse Pharmaceuticals Private Limited was incorporated on 16 January 1985.

Who are the current directors of Finesse Pharmaceuticals Private Limited?

The current directors of Finesse Pharmaceuticals Private Limited are

What is the primary industry of Finesse Pharmaceuticals Private Limited?

The primary industry of Finesse Pharmaceuticals Private Limited is Manufacturing.

Is Finesse Pharmaceuticals Private Limited a listed company?

Finesse Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Finesse Pharmaceuticals Private Limited?

The authorized capital of Finesse Pharmaceuticals Private Limited is ₹5.50 M, and the paid-up capital is ₹4.09 M.

What is the compliance status of Finesse Pharmaceuticals Private Limited?

The compliance status of Finesse Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available